PRESS RELEASE
News
-
-
PRESS RELEASE
Jaguar Health Reports 2024 Financials: 2024 Net Revenue Up Approximately 20% Over 2023
Jaguar Health, Inc. reports a 20% increase in total net revenue for 2024, reaching $11.7 million. Expecting first results in Q2 2025 for crofelemer trials. FDA meeting scheduled for Phase 3 OnTarget trial -
-
PRESS RELEASE
Tharimmune Announces Positive FDA Feedback on NDA Path for TH104 for Prophylaxis of Respiratory and/or CNS Depression for Ultrapotent Opioid Exposure
Tharimmune received positive feedback from the FDA on the 505(b)(2) NDA submission for TH104 buccal film for opioid prophylaxis. Company progressing CMC plan for NDA requirements -
-
-
-
-
PRESS RELEASE
Jericho Energy Ventures Unveils Innovative Modular Data Center Initiative, Transforming Natural Gas Assets into AI Powerhouses
Jericho Energy Ventures Inc. announces the launch of its Modular Data Center venture utilizing natural gas assets for AI computing solutions amidst Trump administration's pro-energy landscape -
PRESS RELEASE
Silver X Mining Announces Grant of Incentive Stock Options and Restricted Share Units
Silver X Mining Corp. grants 450,000 restricted share units and 700,000 stock options to directors and officers as part of its omnibus incentive plan. The company aims to increase production and value while upholding environmental and community sustainability
